FDA issued National Priority Vouchers to Compass Pathways and Usona Institute, accelerating psychedelic drug review.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA issued National Priority Vouchers to Compass Pathways and Usona Institute, accelerating psychedelic drug review.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Compass
Credit institution that offers online loans, personal financing, and other financial products.
-
Usona Institute
nonprofit organization in Madison, United States
Nothing else this week.
Related events
- An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.
- Richard Langford provided expert comments on psychedelic drug access and is receiving feedback on clinical psychedelic programs.
- The FDA has issued guidance outlining the clinical trial requirements for new drug classes, including psychedelic drugs.
- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.